scispace - formally typeset
E

Eric Chokunonga

Researcher at Parirenyatwa Hospital

Publications -  30
Citations -  2092

Eric Chokunonga is an academic researcher from Parirenyatwa Hospital. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 13, co-authored 28 publications receiving 1474 citations.

Papers
More filters
Journal ArticleDOI

International incidence of childhood cancer, 2001-10 a population-based registry study

Eva Steliarova-Foucher, +229 more
- 01 Jun 2017 - 
TL;DR: This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals.
Journal ArticleDOI

Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.

TL;DR: Cancer control in Zimbabwe, as elsewhere in sub‐Saharan Africa, involves meeting the challenge of emerging cancers associated with westernization of lifestyles (large bowel, breast and prostate), while the incidence of cancersassociated with poverty and infection shows little decline, and the residual burden of the AIDS‐associated cancers remains significant.
Journal ArticleDOI

Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995.

TL;DR: The most significant change in rates is the striking increase in the incidence of Kaposi's sarcoma in both men and women, compatible with the evolution of the AIDS epidemic in sub‐Saharan Africa.
Journal ArticleDOI

Aids and cancer in Africa: the evolving epidemic in Zimbabwe.

TL;DR: The AIDS epidemic has had a dramatic effect on the profile of cancer in Zimbabwe, and changes in incidence involve several cancers previously linked to AIDS in North America and Europe.
Journal ArticleDOI

Cancer in the african population of harare, Zimbabwe, 1990–1992

TL;DR: In the African population in Zimbabwe there are high rates of liver, prostate and cervix cancer, low rates of large‐bowel cancer and breast cancer, but there is not much evidence for an increase in incidence of non‐Hodgkin lymphomas nor, although rates are very high, of cervical cancer.